biuro@scopefluidics.com +48 22 376 21 14

About
Team
Our offer
Knowledge base
News
Investor relations
Career
Contact

biuro@scopefluidics.com +48 22 376 21 14

About
Team
Our offer
Knowledge base
News
Investor relations
Career
Contact

biuro@scopefluidics.com +48 22 376 21 14

RAPORT ESPI 2/2019 | 07-03-2019 | Uszczegółowienie harmonogramu rozwoju systemu PCR|ONE i przyspieszenie prac nad systemem BacterOMIC

Previous PostRAPORT KWARTALNY 3/2019 | 14-02-2019 | Jednostkowy i skonsolidowany raport okresowy za IV kwartał 2018 rokuNext PostRAPORT ESPI 3/2019 | 12-03-2019 | Rozszerzenie współpracy z Clairfield

0Shares

Related Posts

Scope Fluidics Fellowship is back – 2nd edition coming soon!

SCOPE FLUIDICS0

Scope Fluidics enters into a distribution agreement in the Turkish market

SCOPE FLUIDICS0

Scope Fluidics Q1–Q3 2025 Results: Secures a stronger cash position and appoints a leading transaction advisor

SCOPE FLUIDICS0

CONTACT US

Tel. +48 22 376 21 14
Email: biuro@scopefluidics.com

Address

Ogrodowa 58
9th floor
00-876 Warsaw

KRS: 0000668408

NIP: 527-264-59-89

REGON: 142-754-170

LEI: 259400EUNFX4E2BEHU15

Company registered in the District Court for the Capital City of Warsaw in Warsaw, XII Commercial Division of the National Court Register.

Share capital: PLN 316 827,10 fully paid up

Bank Account Number: 03 2490 0005 0000 4520 3046 2136

Terms of use

Cookies Policy

Information clause

Whistleblower Protection

Scope Fluidics 2021 ® All rights reserved